Home

Dare Bioscience, Inc. - Common Stock (DARE)

2.2000
+0.00 (0.00%)
NASDAQ · Last Trade: Aug 18th, 4:03 AM EDT
QuoteNewsPress ReleasesChartHistoricalFAQAboutCompetitors

Detailed Quote

Previous Close2.200
Open-
Bid2.110
Ask2.170
Day's RangeN/A - N/A
52 Week Range1.830 - 9.190
Volume0
Market Cap155.15M
PE Ratio (TTM)-1.023
EPS (TTM)-2.1
Dividend & YieldN/A (N/A)
1 Month Average Volume352,481

Chart

About Dare Bioscience, Inc. - Common Stock (DARE)

Dare Bioscience Inc is a biotechnology company focused on the development and commercialization of innovative therapeutic solutions, particularly in women's health care. The company is dedicated to addressing unmet medical needs by creating products aimed at enhancing reproductive health, contraception, and various gynecological conditions. With a portfolio of proprietary and partnered therapies, Dare Bioscience combines scientific expertise and cutting-edge technologies to deliver effective treatment options that improve the quality of life for women. Read More

News & Press Releases

Daré Bioscience Posts Narrower Q2 Lossfool.com
Via The Motley Fool · August 14, 2025
12 Health Care Stocks Moving In Thursday's After-Market Sessionbenzinga.com
Via Benzinga · August 14, 2025
Earnings Scheduled For August 14, 2025benzinga.com
Via Benzinga · August 14, 2025
A Preview Of Dare Bioscience's Earningsbenzinga.com
Via Benzinga · August 13, 2025
Unusual volume stocks are being observed in Tuesday's session.chartmill.com
The trading volume of these stocks is deviating from the norm in today's session.
Via Chartmill · July 15, 2025
US Stocks Close Mixed As Tariff Concerns Rise: Investor Sentiment Improves, Fear & Greed Index Remains In 'Extreme Greed' Zonebenzinga.com
Via Benzinga · July 15, 2025
Dare Bioscience's Earnings Outlookbenzinga.com
Via Benzinga · May 12, 2025
A Look Ahead: Dare Bioscience's Earnings Forecastbenzinga.com
Via Benzinga · March 28, 2025
Synergy (NASDAQ: SNYR) Strategic Partnership w/ McKesson (NYSE: MCK) Sends “FOCUSfactor” Exploding Across North America – More Stocks Inside
Synergy CHC Corp. (NASDAQ: SNYR) is capturing national attention with the announcement of a strategic distribution partnership with McKesson Canada, a division of McKesson Corporation (NYSE: MCK) . The agreement gives FOCUSfactor® direct access to thousands of pharmacies and health-focused retailers across Canada, igniting the next phase of its aggressive North American expansion.
Via AB Newswire · July 14, 2025
These stocks are moving in today's sessionchartmill.com
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · July 14, 2025
Crude Oil Moves Lower; Daré Bioscience Shares Jumpbenzinga.com
Via Benzinga · July 14, 2025
Insights into Dare Bioscience's Upcoming Earningsbenzinga.com
Via Benzinga · November 13, 2024
12 Health Care Stocks Moving In Monday's Intraday Sessionbenzinga.com
Via Benzinga · July 14, 2025
Unusual volume stocks in Monday's sessionchartmill.com
Unusual volume stocks in Monday's session
Via Chartmill · July 14, 2025
Which stocks are moving on Monday?chartmill.com
Curious about what's happening in today's session? Check out the latest stock movements and price changes.
Via Chartmill · July 14, 2025
Let's uncover which stocks are experiencing notable gaps during today's session.chartmill.com
Traders are paying attention to the gapping stocks in Monday's session. Let's dive into which stocks are experiencing notable gaps.
Via Chartmill · July 14, 2025
US Stocks Edge Lower; Fastenal Posts Upbeat Earningsbenzinga.com
Via Benzinga · July 14, 2025
12 Health Care Stocks Moving In Monday's Pre-Market Sessionbenzinga.com
Via Benzinga · July 14, 2025
12 Health Care Stocks Moving In Friday's Pre-Market Sessionbenzinga.com
Via Benzinga · July 11, 2025
12 Health Care Stocks Moving In Wednesday's Pre-Market Sessionbenzinga.com
Via Benzinga · June 4, 2025
Earnings Scheduled For May 13, 2025benzinga.com
Via Benzinga · May 13, 2025
Earnings Scheduled For March 31, 2025benzinga.com
Via Benzinga · March 31, 2025
DARE Stock Earnings: Dare Bioscience Beats Revenue for Q2 2024investorplace.com
DARE stock results show that Dare Bioscience beat on revenue for the second quarter of 2024.
Via InvestorPlace · August 12, 2024
Earnings Scheduled For November 14, 2024benzinga.com
Via Benzinga · November 14, 2024
12 Health Care Stocks Moving In Thursday's Intraday Sessionbenzinga.com
Via Benzinga · May 30, 2024